Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Uscom Ltd

UCM
Current price
0.041 AUD 0 AUD (0.00%)
Last closed 0.041 AUD
ISIN AU000000UCM2
Sector Healthcare
Industry Medical Devices
Exchange Australian Securities Exchange
Capitalization 10 348 190 AUD
Yield for 12 month -16.33 %
1Y
3Y
5Y
10Y
15Y
UCM
21.11.2021 - 28.11.2021

Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. The company also provides the SpiroSonic Ultrasonic spirometer, a pulmonary function testing device that uses multi-path ultrasound; SpiroSonic FLO and SpiroSonic AIR, a digital multi-path ultrasonic spirometer for pulmonary function diagnostic and monitoring COPD and asthma; and SpiroSonic SMART for use by general practitioners and patients for screening COPD and asthma. It serves hospitals and other medical care locations through its distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia. Address: 66 Clarence Street, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

0.46 AUD

P/E ratio

Dividend Yield

Current Year

+3 755 382 AUD

Last Year

+2 684 566 AUD

Current Quarter

+1 785 324 AUD

Last Quarter

+1 722 439 AUD

Current Year

+3 139 552 AUD

Last Year

-1 033 660 AUD

Current Quarter

+1 420 777 AUD

Last Quarter

-175 644 AUD

Key Figures UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -1 816 628 AUD
Operating Margin TTM -62.47 %
PE Ratio
Return On Assets TTM -23.53 %
PEG Ratio
Return On Equity TTM -67.97 %
Wall Street Target Price 0.46 AUD
Revenue TTM 3 755 381 AUD
Book Value 0.013 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 26 %
Dividend Yield
Gross Profit TTM 2 262 656 AUD
Earnings per share -0.01 AUD
Diluted Eps TTM -0.01 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -55.67 %

Dividend Analytics UCM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation UCM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 2.3449
Price Sales TTM 2.7556
Enterprise Value EBITDA -2.7179
Price Book MRQ 3.3549

Financials UCM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators UCM

For 52 weeks

0.011 AUD 0.049 AUD
50 Day MA 0.019 AUD
Shares Short Prior Month
200 Day MA 0.022 AUD
Short Ratio
Shares Short
Short Percent